Showing 5071-5080 of 5771 results for "".
- Harrow Health Forms Stowe Pharmaceuticals Subsidiary to Develop Anti-Microbial Ophthalmic and Otic Therapeuticshttps://modernod.com/news/harrow-health-forms-stowe-pharmaceuticals-subsidiary-to-develop-anti-microbial-ophthalmic-and-otic-therapeutics/2479553/Harrow Health announced that its newly formed subsidiary, Stowe Pharmaceuticals, has entered into an agreement with TGV Health to acquire worldwide rights to the Zian anti-microbial molecule for ophthalmic and otic uses. Zian is a patented small molecule that is water soluble, colorless,
- US Outlines Plans to Allow Importation of Certain Prescription Drugs From Canada, Other Countrieshttps://modernod.com/news/us-outlines-plans-to-allow-importation-of-certain-prescription-drugs-from-canada-other-countries/2479556/The US Department of Health and Human Services (HHS) on Wednesday outlined details of two potential pathways that will allow the importation of certain prescription medicines originally intended for foreign markets. The announcement comes the day after HHS Secretary Alex Azar confirmed that Presi
- Acuity Eyecare Group Enters Texas Market With Multiple Acquisitionshttps://modernod.com/news/acuity-eyecare-group-enters-texas-market-with-multiple-acquisitions/2476785/Riata Capital Group announced that its portfolio company Acuity Eyecare Group, an owner and operator of North American eyecare groups and optometry practices, has acquired 11 regional eyecare practices in Texas. These acquisitions are the first for Acuity Eyecare
- EssilorLuxottica, Maker of Ray-Ban Sunglasses, Agrees to Buy GrandVision in $8 Billion Dealhttps://modernod.com/news/ray-ban-maker-agrees-to-buy-grandvision-for-8-billion/2479558/A blockbuster deal in the eyecare retail space was announced on Wednesday as EssilorLuxottica, the maker of Ray-Ban sunglasses, agreed to buy Dutch retailer GrandVision NV in multi-billion dollar deal. Paris-based EssilorLuxottica agreed to buy control (77%) of European rival GrandVision f
- Schwind: More Than 6 Million Treatments Performed With Amaris Eximer Laserhttps://modernod.com/news/schwind-more-than-6-million-treatments-with-amaris-eximer-laser/2479559/Schwind eye-tech-solutions announced that its Amaris eximer lasers have been installed in 100 countries with more than 6 million treatments performed to date. With 3.1 million treatments (52 percent), LASIK performed
- Bausch + Lomb Initiates First Clinical Trial for Technolas Teneo Excimer Laser in the United Stateshttps://modernod.com/news/bausch-lomb-initiates-first-clinical-trial-for-technolas-teneo-excimer-laser-in-the-united-states/2479560/Bausch + Lomb announced that it has initiated the first in a series of U.S. clinical trials to evaluate the safety and efficacy of the Technolas Teneo excimer laser for vision correction surgery for myopia and myopic astigmatism. “This is an exciting milestone for our organization, as it’s
- Altris AI Algorithm for Detection of Retinal Conditions on OCT Scans Receives European CE Mark Approvalhttps://modernod.com/news/altris-ai-algorithm-for-detection-of-retinal-conditions-on-oct-scans-receives-european-ce-mark-approval/2479561/Altris AI announced that it has received the CE Mark approval for its Standard Functionality for retinal conditions detection on Optical Coherence Tomography (OCT) scans. Altris AI Standard Functionality is ready for preliminary screening of retinal diseases in clinical practice. Altris AI detect
- Johnson & Johnson Vision Launches New Surgical Vision Experience Center at the Johnson & Johnson Institute in Jacksonvillehttps://modernod.com/news/johnson-johnson-vision-launches-new-surgical-vision-experience-center-at-the-johnson-johnson-institute-in-jacksonville/2476784/Johnson & Johnson Vision announced today the launch of the Surgical Vision Experience Center at the Johnson & Johnson Institute in Jacksonville, Florida. The center will serve as Johnson & Johnson Vision’s premier physical t
- Now Optics Launches New Advertising Campaign ‘The Perfect Fit’https://modernod.com/news/now-optics-launches-new-advertising-campaign-the-perfect-fit/2476780/Now Optics, which provides eyewear under the retail brands Stanton Optical and My Eyelab, has announced a new advertising campaign, ‘The Perfect Fit.’ Developed in conjunction with its agency, Barkley, ‘The Perfect Fit’ highlights walk-in eye exam appointments, eyeglasses and eyewear assor
- Alkahest Phase 2a Study AKST4290-202 in Refractory Wet AMD Meets Primary and Secondary Endpointshttps://modernod.com/news/alkahest-phase-2a-study-akst4290-202-in-refractory-wet-amd-meets-primary-and-secondary-endpoints/2476778/Alkahest announced that its phase 2a trial of AKST4290, an orally-administered small molecule CCR3 inhibitor, met the primary endpoint of achieving an increase in best corrected visual acuity (BCVA) in patients with refractory wet or neovascular age-related macular degeneration (nAMD). AKST4290 w